Commercial
  
MPNewsFlashTopicPub
MPPurposePub
  
  
  
  
10/15/2021
Coverage of the COVID-19 Vaccination for Independence Commercial Members (updated October 15, 2021)

The purpose of this communication is to provide notice regarding information and procedure codes related to the coverage of SARS-CoV-2 (Corona​virus Disease 2019 (COVID-19)) vaccines and administration of the vaccines for Independence commercial members. This policy communication addressing COVID-19 vaccine for Independence commercial members has been updated retro-effective to September 22, 2021.


0.1Coverage of the COVID-19 Vaccination for Independence Commercial Members (updated October 15, 2021)9b525c7e-77dd-4ec6-a8a1-c92716451a8a
10/1/2021
Consumer Grade Pulse Oximetry Devices For Use In The Home Setting (Updated October 01, 2021)

The purpose of this NewsFLASH is to provide advance notice during the COVID-19 outbreak related to the coverage of consumer grade pulse oximetry devices for use in the home setting.

The coverage of consumer grade pulse oximetry devices for use in the home setting is effective from June 1, 2020 and will be reevaluated for continuing applicability on December 31, 2021.

0.1Consumer Grade Pulse Oximetry Devices For Use In The Home Setting (Updated October 01, 2021)ba205205-c407-41f2-bba9-b9cdab71f9ff
10/1/2021
10/1/2021 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products
The intent of this article is to communicate Commercial Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 10/1/2021, unless otherwise noted.

For more information related to these services, please refer to specific policies when applicable.​​​​​

0.110/1/2021 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products490ecf35-0761-440c-b534-a035b758d9eb
9/23/2021
Coverage of Speech Therapy Services Performed Through Telemedicine for Independence Commercial Members

The purpose of this communication is to provide notice regarding coverage for speech therapy services performed through telemedicine for our Independence Commercial members during the coronavirus disease 2019 public health emergency. 

This communication addressing coverage of speech therapy performed through telemedicine is effective from March 6, 2020 through January 1, 2022 and will be reviewed for continued coverage during the public health emergency.​


0.1Coverage of Speech Therapy Services Performed Through Telemedicine for Independence Commercial Members2a7b4a53-07cb-477b-b865-92bb77e0c8f1
9/23/2021
Withdrawal of Advance Notification of Future Policy #00.10.41i: Telemedicine Services Scheduled to Become Effective 10/1/2021 for Independence Commercial Members
The purpose of this communication is to provide notice of withdrawal of our Advance Notification of Future Policy #00.10.41i: Telemedicine Services (Independence), initially scheduled to become effective on October 1, 2021.  The current version of Policy #00.10.41h: Telemedicine Services (Independence), which became effective on July 1, 2021, will continue to communicate our telemedicine coverage position on behavioral health services.

0.1Withdrawal of Advance Notification of Future Policy #00.10.41i: Telemedicine Services Scheduled to Become Effective 10/1/2021 for Independence Commercial Members470810d2-b2ab-4a0d-a910-0706c9489ea8
9/17/2021
Preventive Coverage of Work-up and Follow-up Services for Pre-exposure Prophylaxis for the Prevention of HIV for Independence Members
The purpose of this communication is to provide notice regarding the preventive coverage of services received by an individual prior to beginning pre-exposure prophylaxis for the prevention of HIV and on-going follow-up and monitoring​ for Independence members.
1Preventive Coverage of Work-up and Follow-up Services for Pre-exposure Prophylaxis for the Prevention of HIV for Independence Members7bb86f43-944b-46f0-b5b6-ce37e0d34afb
9/13/2021
Pharmaceutical Treatments of COVID-19 for Independence Commercial Members (Updated October 6, 2021)

The purpose of this document is to communicate the Company's coverage position for Pharmaceutical Treatment of COVID-19 for Independence commercial members. 

0.1Pharmaceutical Treatments of COVID-19 for Independence Commercial Members (Updated September 13, 2021)56f1c3f3-0549-461c-ade4-0cbb51ce3d67
8/19/2021
Expanded Coverage of Recombinant zoster vaccine (Shingrix) for Independence Commercial Members

The purpose of this communication is to provide notice regarding the expanded coverage criteria for recombinant zoster vaccine (Shingrix)​ for Independence commercial members effective July ​​26, 2021.
0.1Expanded Coverage of Recombinant zoster vaccine (Shingrix) for Independence Commercial Members 94e4b1cb-b822-46be-becc-3021ad3823f4
8/12/2021
ADUHELM™ (aducanumab-avwa) injection (for Commercial Members)
The purpose of this communication is to provide notification of ​the Company's position for ADUHELM™ (aducanumab-avwa) injection​ for all Commercial Products effective as of June 7, 2021.
0.1ADUHELM™ (aducanumab-avwa) injection (for Commercial Members)d7e35b78-454d-40c3-97ad-2fda88a74d71
7/26/2021
Preventive Coverage of Colorectal Cancer Screening for Independence Commercial Members
The purpose of this document is to provide advance notice regarding preventive coverage for colorectal cancer screening for our Independence commercial members.

0.1Preventive Coverage of Colorectal Cancer Screening for Independence Commercial Membersbaccdfeb-27f3-42e7-a57b-895eef365972
6/15/2021
Notification of Upcoming Changes to Pharmacologic Nuclear Stress Testing in response to COVID-19
The purpose of this NewsFlash is to provide advance notice that medical necessity reviews will resume for new prior authorization requests on or after July 15, 2021 regarding the use of pharmacologic stress testing with nuclear imaging in lieu of exercise stress testing​. 
0Notification of Upcoming Changes to Pharmacologic Nuclear Stress Testing in response to COVID-192b76b463-a26c-4b24-b3f3-b98732caee8e
4/20/2021
Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Commercial Independence Members (Updated October 6, 2021)
The purpose of this communication is to provide advance notice regarding information and procedure codes related to testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Commercial Independence members.
 
This communication addressing Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) is effective from March 6, 2020 through December 31, 2021, or the duration of the Public Health Emergency.

 
Note: Information related to SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) is continuously evolving. The Company is closely monitoring the outbreak caused by the novel coronavirus, and will update our communications accordingly. ​

 
  • This document replaces the version published on March 19, 2021.
  • Language in the section for SPECIMENS COLLECTED BY A MEMBER was revised for clarity.​

0Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Commercial Independence Members (Updated June 16, 2021)e608b28d-f17e-4672-a1d3-39e5eed12c77
4/1/2021
4/1/2021 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products
The intent of this article is to communicate Commercial Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 4/1/2021, unless otherwise noted.


0.14/1/2021 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Productsc832c919-e231-49f5-b0dc-09bc2f5e33b7
1/4/2021
1/1/2021 CPT & HCPCS Annual Code Update Coverage Determinations for Commercial Products
The intent of this document is to communicate Commercial Product coverage determinations for services identified through the Annual Code Update process. 
01/1/2021 CPT & HCPCS Annual Code Update Coverage Determinations for Commercial Productsb976b7b6-ff87-4f04-a559-d2f8805e0586
10/1/2020
10/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products
The intent of this article is to communicate Commercial Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 10/1/2020, unless otherwise noted.

For more information related to these services, please refer to specific policies when applicable.​

110/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Productsc322926f-ec73-4821-aac6-943615dd055a
7/1/2020
7/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products
17/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products5D38243F686BE26685258598006308EB
5/12/2020
Pharmacologic Nuclear Stress Testing in Response to COVID-19 (Updated June 15, 2021)​
The purpose of this News Article is to provide advance notice regarding the use of pharmacologic stress testing with nuclear imaging in response to the Public Health Emergency (PHE) for the COVID-19 pandemic.
1Pharmacologic Nuclear Stress Testing in Response to COVID-19 (Updated June 15 2021)5A7DE68A793E25EB852585650075011A
4/29/2020
Direct Supervision Requirements for Incident to Services Performed by Certified Registered Nurse Practitioners (CRNPs) and Physician Assistants (PAs) in Response to COVID-19 (Updated October 7, 2021)​
The purpose of this News Article is to provide advance notice regarding direct supervision requirements for Incident to services performed by Certified Registered Nurse Practitioners (CRNPs) and Physician Assistants (PAs) in response to Coronavirus Disease 2019 (COVID-19).
1Direct Supervision Requirements for Incident to Services Performed by Certified Registered Nurse Practitioners (CRNPs) and Physician Assistants (PAs) in Response to COVID-19 (Updated June 16, 2021)CC0B8A7BBD74419185258558007CCF61
4/1/2020
4/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products (revised 05/04/2020)
The intent of this news article is to communicate Commercial Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 4/1/2020.
14/1/2020 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products (revised 05/04/2020)7826A7FDF85578D38525855E004A1326
12/27/2019
1/1/2020 CPT & HCPCS Annual Code Update Coverage Determinations for Commercial Products
The intent of this article is to communicate Commercial Product coverage determinations for services identified through the Annual Code Update process. The procedure codes that represent these services will become effective on 1/1/2020.
11/1/2020 CPT & HCPCS Annual Code Update Coverage Determinations for Commercial Products878452BEE2294FD4852584DD004BB52E
10/1/2019
10/1/2019 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products
The intent of this article is to communicate Commercial Product coverage positions for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 10/1/2019.
110/1/2019 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products321EEF85779238BD85258486004A8212
8/8/2019
Clinical Appropriateness Guidelines for Radiology to be updated for Independence Commercial Members
The purpose of this news article is to provide advance notice regarding upcoming AIM Clinical Appropriateness Guidelines for Radiology for Independence Commercial Members.
1Clinical Appropriateness Guidelines for Radiology to be updated for Independence Commercial MembersAE4CC970FD87BFDD852584500072AB0F
7/1/2019
7/1/2019 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products
The intent of this article is to communicate Commercial Product coverage positions for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 7/1/2019.
17/1/2019 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products5F5B3FF86094E6EF8525842A006CBA5C
5/14/2018
Meniscal allograft transplantation performed in combination with treatment of focal articular cartilage lesions
The purpose of this communication is to provide notice regarding coverage position of meniscal allograft transplantation performed in combination with treatment of focal articular cartilage lesions.
1Meniscal allograft transplantation performed in combination with treatment of focal articular cartilage lesionsD1785854FDED826B8525828D00670D5E
5/14/2018
​Minimally invasive fusion/stabilization of the sacroiliac joint using a titanium triangular implant
The purpose of this communication is to provide notice regarding updated coverage position for minimally invasive fusion/stabilization of the sacroiliac joint using a titanium triangular implant
1Minimally invasive fusion/stabilization of the sacroiliac joint using a titanium triangular implantF3BC3AC3678CB7708525828D006A66E3